Atomo NewsGet the app

Get the latest Science News and Discoveries

Insilico Medicine and Qilu Pharmaceutical reach near $120 million drug development collaboration to accelerate novel cardiometabolic therapies - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Insilico Medicine

Insilico Medicine

Photo of Qilu Pharmaceutical

Qilu Pharmaceutical

Related news:

News photo

Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor - EurekAlert!

News photo

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor for inflammatory bowel disease - EurekAlert!

News photo

Insilico Medicine integrates Nach01 Foundation Model with Microsoft Discovery to enable AI-native, enterprise-ready drug discovery workflows - EurekAlert!

« Are mysterious 'Little Red Dots' discovered by the James Webb Space Telescope actually nurseries for direct-collapse black holes?
New study proposes global framework to safeguard world’s most vulnerable regions amid climate crisis - EurekAlert! »